A simple model that suggests possible cost savings when modified-release prednisone 5 mg/day is added to current treatment in patients with active rheumatoid arthritis

M. Boers; F. Buttgereit

doi:https://doi.org/10.1093/rheumatology/ket145

A simple model that suggests possible cost savings when modified-release prednisone 5 mg/day is added to current treatment in patients with active rheumatoid arthritis

M. Boers, F. Buttgereit

Research output: Contribution to journal › Article › Academic › peer-review

21 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1435-1437
Journal	Rheumatology
Volume	52
Issue number	8
DOIs	https://doi.org/10.1093/rheumatology/ket145
Publication status	Published - 2013

Access to Document

https://doi.org/10.1093/rheumatology/ket145

Cite this

@article{970afc2a22224e4fab74128b10a01cfa,

title = "A simple model that suggests possible cost savings when modified-release prednisone 5 mg/day is added to current treatment in patients with active rheumatoid arthritis",

author = "M. Boers and F. Buttgereit",

year = "2013",

doi = "https://doi.org/10.1093/rheumatology/ket145",

language = "Undefined/Unknown",

volume = "52",

pages = "1435--1437",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "8",

}

TY - JOUR

T1 - A simple model that suggests possible cost savings when modified-release prednisone 5 mg/day is added to current treatment in patients with active rheumatoid arthritis

AU - Boers, M.

AU - Buttgereit, F.

PY - 2013

Y1 - 2013

U2 - https://doi.org/10.1093/rheumatology/ket145

DO - https://doi.org/10.1093/rheumatology/ket145

M3 - Article

SN - 1462-0324

VL - 52

SP - 1435

EP - 1437

JO - Rheumatology

JF - Rheumatology

IS - 8

ER -